SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is currently trending due to its exceptionally low public float and high insider ownership, drawing intense comparisons to recent high-flying SPACs like AFJK. The community is highly bullish, anticipating significant price appreciation as a potential business combination announcement approaches for this US-based SPAC. Traders are actively discussing its potential for explosive moves driven by supply scarcity, aligning with patterns observed in other low-float market plays.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to widespread discussion around year-end tax loss selling and persistent selling from early investors, which is currently driving significant downward pressure. Community sentiment remains sharply divided, with some seeing current levels as a compelling buying opportunity given the company's profitability and growth, while others emphasize ongoing dilution concerns and a challenging market backdrop.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to the recent FDA approval of NEREUS (tradipitant), marking the first new motion sickness drug in over four decades. The community is actively discussing its potential to alleviate GLP-1 induced nausea, viewing this as a significant market opportunity and a catalyst for potential buyouts. While some initially expressed mixed reactions to price action, many believe the stock's long-term value and additional pipeline catalysts are not yet fully reflected.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid a contentious and repeatedly postponed shareholder vote on increasing authorized shares, sparking intense debate over its future funding and growth strategy. Bulls anticipate significant, often classified, government contracts and strategic benefits from the Ask Sage acquisition, viewing current price movements as short-term manipulation. Conversely, skeptics express frustration with management, citing a lack of tangible contract announcements and fearing potential dilution, leading to a polarized community discussion.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology Co Ltd (AFJK) is trending as traders speculate on a classic "China IPO squeeze" due to its notably low float and thin share structure. The community is actively discussing its highly volatile, casino-like movements, frequent trading halts, and comparing its potential for rapid price swings to similar recent Chinese tickers.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending amidst intense speculation regarding an unconfirmed FDA decision on its relacorilant drug for Cushing's Syndrome, with community chatter divided between rumored rejection causing panic selling and calls to buy the dip. The immediate uncertainty around this key pipeline asset, alongside its existing revenue-generating drug Korlym and other promising indications like ovarian cancer, fuels a volatile debate among investors.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending amidst mixed analyst sentiment driven by concerns over crypto trading volumes, despite a strong 2025 performance. The community is buzzing with frustration over app glitches and modest rewards from recent holiday giveaways, fueling discussions about the platform's reliability and marketing approach. Investors are keenly watching how its crypto correlation and new ventures like prediction markets will shape its near-term outlook.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is currently experiencing a surge in attention fueled by high expectations for its upcoming earnings report, with the community anticipating strong revenue growth driven by its high-margin drug Recorlev. Investors are also keenly focused on the company's pathway to sustained profitability and the long-term potential of its pipeline, particularly the promising XP-8121, which analysts believe could achieve blockbuster status. This positive outlook is supported by recent analyst target upgrades and a perceived de-risked profile, positioning Xeris for significant growth within the biopharma sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing heightened volatility as the CME implements multiple margin requirement hikes, fueling intense community debate over market manipulation. Many perceive these actions as a concerted effort to suppress prices and liquidate leveraged positions, especially with reported disparities between paper and physical silver values globally. Despite calls of a "rigged game" and comparisons to past crashes, a strong bullish contingent anticipates a significant long-term rally driven by robust industrial demand and ongoing concerns about supply.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to high anticipation for upcoming FDA decisions regarding AXS-05 for Alzheimer's agitation and AXS-12 for narcolepsy, with the community optimistic about potential approvals. This regulatory excitement is complemented by strong, consistent prescription growth and expanding market access for its major depressive disorder treatment, Auvelity. Investors are keenly focused on these catalysts and the company's broader CNS pipeline, despite some impatience with communication around timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is This the Right Time to Bet on Clean Energy ETFs?

Despite policy headwinds, surging AI-driven power demand and falling renewable costs are powering clean energy ETFs higher.

Here's Why Solar & Clean Energy ETFs Are Shining Bright

Solar and other clean energy ETFs like TAN, CTEX, CNRG & CTEC are surging as AI demand, rate cuts & policy relief boost the long-term growth outlook.

5 Best-Performing ETF Areas of Last Week 

ETFs like BITI, EWY, XSD, AMDW, and CNRG have fared well last week on AI momentum, trade optimism and clean energy revival.

Fed Likely to Cut Rate Today: 5 Clean Energy ETFs in Focus

A Fed rate cut today could ease financing for renewables, boosting U.S.-focused clean energy ETFs that are already gaining momentum. 

Inside The Recent Run of Clean Energy & EV ETFs

PBW, QCLN, CNRG, and HAIL have been hovering around 52-week highs as clean energy regulations, Ford's EV plan, Powell's rate cut hints and Tesla rally sparked momentum.

Clean Energy ETFs Hit a 52-Week High: Here's Why 

Clean energy ETFs like ICLN and CTEX surged to 52-week highs after U.S. tax credit guidance eased investor fears and fueled a solar stock rally.

Shares of Canadian Solar were down over 5% in mid-day trading on Thursday after the leading solar manufacturer’s third-quarter results and revenue guidance were below expectations.&nbsp;The company reported a loss of $14 million in its third quarter. Its losses per share were at $0.31, worse than Wall Street’s expectations of&nbsp;a loss of $0.21, according to Stockwtis data.&nbsp;Revenue stood at $1.51 billion, falling short of the estimated $1.71 billion and down 18% from the same quarter last year.“The year-over-year decrease primarily reflects a decline in module ASPs and lower project sales, partially offset by higher battery energy storage solutions sales and higher solar module shipment volume,” the company said in a statement.For the fourth quarter, the Ontario-based company expects revenue between $1.5 billion and $1.6 billion, below the analyst consensus of $2.15 billion.&nbsp;"The solar industry faces significant external and internal challenges. While we have achieved relatively strong results, the outlook remains complex,” commented CEO Shawn Qu.Qu is betting on the company’s early-mover advantage, advanced manufacturing capabilities, and robust international sales network for continued growth in the rapidly expanding energy storage sector.&nbsp;&nbsp;<figure class="image"><img style="aspect-ratio:1294/293;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_05_114020_6c927a0ad0.png" alt="Screenshot 2024-12-05 114020.png" width="1294" height="293"><figcaption>Canadian Solar Sentiment and Message Volume on Dec 5 as of 12:00 p.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock improved to ‘bullish’ (56/100) from ‘bearish’ a day ago, with a double jump in message volume to ‘extremely high’ from ‘normal.’&nbsp;The ticker saw a 100% jump in message count over the last 24 hours, according to Stocktwits data.Users on the platform applauded the company’s strategy of capitalizing on the current market opportunity in the battery business.&nbsp;<stembedurl>https://stocktwits.com/Mousty/message/595235915</stembedurl><stembedurl>https://stocktwits.com/Noleksum_X/message/595232203</stembedurl>In the third quarter, total module shipments recognized as revenue were 8.4 gigawatts (GW), up 1% YoY, including 31 megawatts (MW) for utility-scale projects.For the upcoming quarter, the company expects total module shipments by CSI Solar to be between 8.0 GW to 8.5 GW. and battery storage shipments of 2.0 GWh to 2.4 GWh, including 1.2 GWh for its projects.For the full year, Canadian Solar forecasts module shipments to be in the range of 30 GW to 35 GW and total battery energy storage shipments between 11 GWh to 13 gigawatt-hours (GWh), including approximately 1 GW and 1 GWh, respectively, to the company’s projects.“We ended the quarter with a strong cash position of $2.8 billion, which we will strategically deploy to support our long-term growth plans and strengthen our financial position as we continue to navigate industry challenges,” said Xinbo Zhu, Senior VP and CFO.Canadian Solar’s stock has slipped 50% so far this year.&nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mara-hood-riot-mstr-clsk-surge-bitcoin-hits-100k-mark-on-thursday/cJ9AJkLRLB">Bitcoin Surges Past $100K, Driving Retail Buzz For MARA, HOOD, RIOT, MSTR, CLSK At Thursday’s Market Open</a>&nbsp;

Canadian Solar Stock Tumbles On Q3 Earnings Miss: Retail Keeps Faith

CEO Shawn Qu noted that the solar industry faces significant challenges, and while the company achieved relatively strong results, the outlook remains complex.

Equity

<a href="https://stocktwits.com/symbol/CSIQ">Canadian Solar stock</a> tumbled over 3% in mid-day trading on Wednesday ahead of the company’s third-quarter results.&nbsp;The company’s stock price is approximately $12.14, reflecting a significant decline from its 52-week high of $26.85.&nbsp;The renewable energy company is grappling with falling revenues, narrowing margins, rising operating expenses, and widening losses, compounded by uncertainty surrounding its guidance amidst geopolitical tensions.Last quarter, the company missed earnings per share (EPS) by $0.11, which was followed by a 9.82% increase in the share price the next day.&nbsp;This time, Wall Street is expecting a loss of $0.21 per share on revenue of $1.71 billion.The company’s manufacturing footprint has come under scrutiny following President-elect Donald Trump’s pledge to impose a 25% tariff on goods imported from Canada.While Canadian Solar maintains U.S. manufacturing capacity, which could help mitigate the impact of new trade policies, much of its operations are based in Asia, particularly China, where it could face a 35% U.S. tariff.China and the U.S. together contribute nearly half of the company’s revenue.&nbsp;Analysts have also expressed concerns about a preliminary 78% anti-dumping (AD) tariff on solar products from Thailand, where Canadian Solar has significant production. These potential tariffs could hinder the company’s ability to compete effectively in the U.S. market.Despite challenges in the solar module sector, Canadian Solar’s energy storage business is a bright spot.&nbsp;The company’s energy storage segment has experienced significant growth, with a backlog of about $2.6 billion at the end of the June quarter. Its subsidiary, Recurrent Energy, has expanded its development pipeline to include 27 GW of solar power and 63 GWh of battery energy storage.<figure class="image"><img style="aspect-ratio:1300/294;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_04_135629_22171dbe75.png" alt="Screenshot 2024-12-04 135629.png" width="1300" height="294"><figcaption>Canadian Solar Sentiment and Message Volume on Dec 4 as of 2:00 p.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around Canadian Solar remains in the ‘neutral’ territory but there has been an uptick in chatter to ‘high’ ahead of the company’s earnings results.&nbsp;<stembedurl>https://stocktwits.com/ForgottenPorfolio/message/595067150</stembedurl><stembedurl>https://stocktwits.com/Robingood_Capital_Inc/message/595052764</stembedurl><stembedurl>https://stocktwits.com/Mousty/message/595012785</stembedurl>Canadian Solar’s stock has dipped 53% so far this year.&nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/intel-stock-drops-after-marvell-technology-ceo-matthew-murphy-rejects-rumours/cJ9oGcvRhw">Intel Stock In Focus As Marvell Chief Shoots Down CEO Speculation: Retail Hopes Dampened</a>

Canadian Solar’s stock has dipped 53% so far this year. | Source: Unsplash

Canadian Solar Stock Tumbles Ahead of Q3 Earnings: Retail Investors Stay On The Sidelines

Retail investors are waiting on management commentary around potential tariffs and their impact on the company’s already falling revenue.

SunPower Corporation shares plunged nearly 48% on Friday after a report, which cited dealers, indicated the firm will discontinue supporting new leases, installations and product shipments. Analysts, too, are reportedly of the opinion that the company is likely to be out of business soon, with Guggenheim Securities cutting the price target on the stock to zero and predicting that the stock may be delisted soon.Following the report, retail investor sentiment touched a one-year low, dipping into extremely bearish territory (7/100) supported by high chatter.<figure class="image"><img style="aspect-ratio:789/224;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_19_at_12_59_19_PM_ead2d7bd30.png" alt="Retail sentiment dips into extremely bearish territory for SunPower Corporation" width="789" height="224"><figcaption>Retail sentiment dips into extremely bearish territory for SunPower Corporation</figcaption></figure>Guggenheim analyst Joseph Osha reportedly wrote in a research note that the firm is entering a wind-down process that will likely end in the sale of its remaining assets and the delisting of its equity. There is also indication that the firm might be looking for alternative providers to transfer its sold projects, according to a CNBC report.The firm did try working on its financials and cutting down costs, but has struggled to regain its footing. In April this year, the firm stated that it is moving to a low fixed-cost model that could better flex when the market is up or down. It said it is winding down its SunPower Residential Installation (SPRI) locations and closing SunPower Direct sales. Apart from these measures, SunPower also said it will be reducing its workforce by approximately 1,000 people to better align the business with its new focus.Last month, the company said it has drawn upon a $50 million second tranche of the $175 million second lien term loan from Sol Holding. Sol Holding, which is owned jointly by affiliates of TotalEnergies SE and Global Infrastructure Partners, is the majority owner of SunPower's common stock. SunPower agreed to issue warrants to Sol Holding to purchase up to approximately 33.40 million shares of common stock at an exercise price of $0.01 per share.Despite these steps, it seems the firm has not been able to complete its intended comeback. For now, investors on Stocktwits are debating the merit of these analyst predictions and chiming in with their own, overwhelmingly bearish commentary. Meanwhile, some traders believe a short-term bounce could be in order due to the shares’ swift drop.<figure class="image"><a href="https://stocktwits.com/AnnKan/message/580064226"><img style="aspect-ratio:783/200;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_19_at_1_00_39_PM_9e1d4b6c7e.png" alt="Stocktwits user AnnKan's post on SunPower Corporation" width="783" height="200"></a><figcaption>Stocktwits user AnnKan's post on SunPower Corporation</figcaption></figure> &nbsp;

Analysts Believe SunPower Corporation Stock Could Go To Zero: Retail Investors Don’t Doubt It

Guggenheim analyst Joseph Osha reportedly wrote in a research note that the firm is entering a wind-down process that will likely end in the sale of its remaining assets and the delisting of its equity. 

Guggenheim analyst Joseph Osha reportedly wrote in a research note that the firm is entering a wind-down process that will likely end in the sale of its remaining assets and the delisting of its equity. The Stocktwits sentiment for the stock is in “extremely bearish” territory.

CNRG
SPDR S&P Kensho Clean Power ETF

Feed

News

Sentiment

Fundamentals

Info

Latest CNRG News

CNRGSPDR S&P Kensho Clean Power ETF